Utility of 99mTc-pyrophosphate scintigraphy in diagnosing transthyretin cardiac amyloidosis in real-world practice
-
- Tsutsui Yoshitomo
- Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
-
- Kubota Toru
- Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
-
- Kato Seiya
- Division of Pathology, Saiseikai Fukuoka General Hospital
-
- Nozoe Masatsugu
- Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
-
- Suematsu Nobuhiro
- Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
-
- Okabe Masanori
- Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
-
- Yamamoto Yusuke
- Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
-
- Tsutsui Hiroyuki
- Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
書誌事項
- タイトル別名
-
- Utility of <sup>99 m</sup>Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
この論文をさがす
抄録
<p>Background:Amyloid transthyretin (ATTR) cardiac amyloidosis has now been recognized as one of the major causes of heart failure, especially in elderly patients. The purpose of the present study was to validate the usefulness of technetium-99 m (99 mTc)-pyrophosphate (99 mTc-PYP) scintigraphy in the screening diagnosis for ATTR amyloidosis in daily clinical practice.</p><p>Methods and Results:Ninety-eight patients underwent 99 mTc-PYP scintigraphy in the previous 3 years (PYP positive/negative, 18/80), of whom 29 underwent concomitant endomyocardial biopsy (ATTR positive/negative, 9/20). The sensitivity and specificity of 99 mTc-PYP scintigraphy for the diagnosis of biopsy-proven ATTR amyloidosis were 0.889 and 0.950, respectively. Age, gender, N-terminal prohormone of brain natriuretic peptide (NT-proBNP) level, or electrocardiogram findings did not differ significantly between PYP-positive and PYP-negative patients. Left ventricular (LV) wall thickness was significantly greater in PYP-positive than in PYP-negative patients, but LV ejection fraction or prevalence of atrial fibrillation was similar between groups. In the PYP-positive patients, higher uptake of PYP correlated with younger age and lower NT-proBNP.</p><p>Conclusions: 99 mTc-PYP scintigraphy was useful, with high sensitivity and specificity in the screening diagnosis for ATTR cardiac amyloidosis, which is difficult to diagnose on clinical characteristics alone. 99 mTc-PYP scintigraphy should be considered to elucidate the underlying causes of heart failure, especially in elderly patients based on the higher prevalence of ATTR cardiac amyloidosis in this population.</p>
収録刊行物
-
- Circulation Reports
-
Circulation Reports 1 (7), 277-285, 2019-07-10
一般社団法人 日本循環器学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001288152710272
-
- NII論文ID
- 130007677739
-
- ISSN
- 24340790
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可